Earlier is Better: Identifying and Diagnosing HF Early in Disease Progression
0.75 program creditsISDPA: Dr. Bhatia and Dr. Zirwas Discuss the Itchy Patient
Navigating the 2024-2025 Flu Season: ACIP’s Latest Guidance
Eczema Awareness Month
Strategies for Integrating Flu Vaccination into Routine Patient Care
Bringing Treatment Into Focus: Biomarker-Driven First-Line Therapy for Metastatic Gastric/GEJ Cancers
1.00 creditsEarlier is Better: Identifying and Diagnosing HF Early in Disease Progression
0.75 program creditsPartnering with Patients: Building Effective Communication and Support in HF Care
0.75 program creditsEczema Awareness Month
Strategies for Integrating Flu Vaccination into Routine Patient Care
Poster Pearl: Comparing the Efficiency of Stool-Based CRC Screening Tests
Comprehensive Immunization: Co-Administering Flu, RSV, and COVID-19 Vaccines
Beyond Prevention: Examining the Lesser-Known Benefits of Flu Vaccination
Bringing Treatment Into Focus: Biomarker-Driven First-Line Therapy for Metastatic Gastric/GEJ Cancers
1.00 creditsDry Eye Disease Assessment and Treatment Plans
The Evolving Role of MET TKIs in NSCLC
0.75 creditsNovember 16, 2024
07:00 PM - 08:30 PM CST
Pulmonary Hypertension: Diagnosis, Management, and Updates
November 16, 2024
Chicago, Illinois
Pulmonary Hypertension: Diagnosis, Management, and Updates
Study: Psoriasis Patients with Skin of Color Wait 3x Longer for Diagnosis
Healthcare’s Achilles’ Heel: How Cybercriminals Exploit the Digital Weak Point of Our Health System
Expanding (Our Understanding of) the Mind: The Cutting-Edge of Technologies Revolutionizing Mental Health and Neurology
AI in Healthcare: How Chatbots Can Change the Way Patients Navigate Through Medical Support
A Clinician's Guide to the ACIP Travel Vaccination Recommendations
Optimizing HCC Screening: Strategies to Overcome Common Barriers
What are the challenges in making the right diagnosis in HCM?
0.75 program creditsOctober 25, 2024
11:00 AM - 11:45 AM ET
Differentiating Biomarker-Driven First-Line Treatment Strategies in Metastatic Gastric/GEJ Cancers
The Burden of TED
1.00 program creditsTreatment Intensification in HR+/HER2- EBC: Who and When?
1.25 program creditsEndpoints in Adjuvant Breast Cancer Trials: Implications for Clinical Practice
1.25 program creditsHow Antibody-Based Therapies Are Revolutionizing Its Management
0.25 creditsNavigating mCRC: A Closer Look at Biomarker Testing
Pathophysiology and Treatment of Macular Edema Following Retinal Vein Occlusion
Evolving Erosive GERD Therapeutics: Insights into a Treatment Option with a Novel MOA
Macular Edema Following Retinal Vein Occlusion: Phase III Clinical Trial Outcomes
Pathophysiology of Bronchiectasis
Helping Ensure Adequate Tissue Sampling Within the MDT